Career Development Program

职业发展计划

• 批准号: 8588560
• 负责人: Lawrence S Kirschner
• 金额: $ 8.83万
• 依托单位: OHIO STATE UNIVERSITY
• 依托单位国家: 美国
• 财政年份: 2013
• 资助国家: 美国
• 起止时间: 2013-09-25 至 2018-07-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/8588560
• 关键词: Academia; Area; Attention; Cancer Center; Development; Diagnosis; Discipline; Disease; Distant; Eligibility Determination; Environment; Epidemiology; Etiology; Faculty; Funding; Future; Grant; Incidence; Individual; Instruction; Leadership; Malignant Neoplasms; Malignant neoplasm of thyroid; Mentors; Mentorship; Minority; Ohio; Patients; Peer Review; Positioning Attribute; Postdoctoral Fellow; Prevention; Process; Qualifying; Recommendation; Research; Research Personnel; Resources; Science; Scientist; Talents; Training; Translational Research; Universities; Woman; anticancer research; base; career; career development; clinical practice; member; novel strategies; programs; stem; success

The development of translational researchers in thyroid cancer requires a diligent commitment to the identification of talented researchers at the junior level, and the placement pf these individuals into a supportive environment which provides not only significant expertise in thyroid cancer, but also the provision for mentorship. Another way to produce leaders in the field of thyroid cancer research is to encourage successful translational scientists to re-focus their talents from other areas into this area. The Career Development Program (CDP) of this thyroid cancer SPORE is an essential component of the application because it provides the mechanism to encourage excellent junior scientists to establish careers in this field and to attract the expertise of established researchers from other disciplines. For this thyroid cancer-focused application, the combination of resources (both patient and research resources) and guidance present at The Ohio State University (OSU) and at the MD Anderson Gancer Center (MDACC) provides an unparalleled environment to enable these new and junior investigators to succeed as independent researchers and to develop future careers which will contribute to progress in stemming the rising incidence of this malignancy and develop new therapies for those with local and distant metastatic disease. To this end, the CDP will fund promising young investigators or, in certain circumstances, more senior faculty reorienting from clinical practice or another field for 2 years at $50,000 per year. Special attention will be paid to the recruitment of applicants from diverse backgrounds. Applications will be solicited from all departments and centers at OSU and MDACC. They will be screened for eligibility by CDP Leadership to assure adequate representation from qualified women and minorities. Applications will be judged based on the potential of the candidate, the strength of the proposed research and the appropriateness of the mentor. Applications will be scored and ranked by members of the CDP Committee and final funding recommendations made to the SPORE Steering Committee. Each position will be funded for one year, with a second year dependent upon satisfactory progress. Over the course of the grant, the SPORE will provide 44.6% of the funding for the CPD, which will be matched by 38.1%, and 17.3% provided from OSUCCC and MDACC, respectively. Success of the program will be judged by the quality of the science generated by the awardees, their success in obtaining external peer-reviewed funding, their success in academic advancement, and their retention in academia and translational research in thyroid cancer. RELEVANCE (See instructions): The Career Development Program (CDP) is an important component of this thyroid cancer SPORE application and the national SPORE program because it will assure a cadre of academic faculty who are specially trained translational scientists and clinicians dedicated to discover and apply new approaches to understanding the etiology and epidemiology, prevention, diagnosis, treatment and cure of patients with thyroid cancer.

甲状腺癌转化研究人员的发展需要勤奋致力于 识别初级水平的有才华的研究人员，并将这些人安置到 支持性环境不仅提供甲状腺癌方面的重要专业知识，还提供 进行指导。培养甲状腺癌研究领域领导者的另一种方法是鼓励 成功的转化科学家将他们的才能从其他领域重新集中到这个领域。职业生涯 甲状腺癌 SPORE 的开发计划 (CDP) 是该应用程序的重要组成部分 因为它提供了鼓励优秀青年科学家在该领域创业的机制 并吸引其他学科知名研究人员的专业知识。对于这个以甲状腺癌为重点的 应用程序、资源（患者和研究资源）和指导的结合 俄亥俄州立大学 (OSU) 和 MD 安德森甘瑟中心 (MDACC) 提供了无与伦比的 使这些新的和初级研究人员能够作为独立研究人员取得成功并 发展未来的职业，这将有助于遏制这种恶性肿瘤发病率上升的进展 并为患有局部和远处转移性疾病的患者开发新疗法。 为此，CDP 将资助有前途的年轻研究人员，或者在某些情况下资助更资深的研究人员 教师从临床实践或其他领域重新定位，为期 2 年，每年 50,000 美元。会特别注意 为招聘来自不同背景的申请人提供报酬。将会向所有人士征集申请 OSU 和 MDACC 的部门和中心。 CDP 领导层将对他们进行资格筛选 确保合格的妇女和少数群体有足够的代表性。申请将根据以下条件进行评判 候选人的潜力、拟议研究的实力以及导师的适当性。 CDP委员会成员将对申请进行评分和排名，并最终提供资助 向 SPORE 指导委员会提出建议。每个职位将获得一年的资助， 第二年取决于令人满意的进展。在资助期间，SPORE 将提供 CPD 资金的 44.6%，其中 38.1% 与 OSUCCC 和 OSUCCC 提供的 17.3% 相匹配。 分别是MDACC。该计划的成功将取决于该计划所产生的科学质量 获奖者、他们在获得外部同行评审资金方面的成功、他们在学术上的成功 进步，以及他们在学术界和甲状腺癌转化研究中的保留。 相关性（参见说明）： 职业发展计划 (CDP) 是甲状腺癌 SPORE 的重要组成部分 申请和国家 SPORE 计划，因为它将确保一支学术骨干队伍 经过专门培训的转化科学家和临床医生致力于发现和应用新方法 了解患者的病因和流行病学、预防、诊断、治疗和治愈 甲状腺癌。